Journal of Alternative Complementary & Integrative Medicine Category: Medicine Type: Review Article

A study on the Compatibility of Crude Drugs Comprising Kampo Medicines

Tetsuya Isobe1*, Koichi Yoneyama1, Mikako Kaijima1 and Hirotsune Kaijima1
1 Kawasaki Satellite of Minatomirai Yume Clinic: Roundcross Kawasaki 8F Ekimaehonnmachi 26-4 Kawasaki, Kawasaki, Kanagawa, Japan

*Corresponding Author(s):
Tetsuya Isobe
Kawasaki Satellite Of Minatomirai Yume Clinic: Roundcross Kawasaki 8F Ekimaehonnmachi 26-4 Kawasaki, Kawasaki, Kanagawa, Japan
Email:iso12-7@blue.ocn.ne.jp

Received Date: Oct 29, 2025
Accepted Date: Nov 06, 2025
Published Date: Nov 13, 2025

Abstract

Introduction: An herbal formulation typically consists of several crude drugs, and their unique combinations have therapeutic effects. The combination of these constituent crude drugs in herbal medicines has been naturally selected over a long period of time into good compatibility. The compatibility of pairs of the crude drugs in herbal medicines has not been elucidated. 

Subjects and Methods: The compatibility of crude drugs in 324 herbal formulations that are frequently used was investigated. Non-coexisting pairs of crude drugs were examined using Excel. 

Results: Based on the current results, bellflower, pinellia tuber, and bupleurum root were identified as crude drugs that may be incompatible with aconite. Schizonepeta spike was identified as a crude drug that is potentially incompatible with ginseng. Polyporus and perilla herb were identified as crude drugs that are potentially incompatible with peony. Pinellia tuber may be most incompatible with rehmannia root. There were no crude drugs that were incompatible with licorice or ginger. 

Discussion: When one wishes to add powdered aconite extract to a formulation for its “warming and analgesic action,” it should probably not be taken at the same time the formulation which include bellflower, pinellia tuber, or bupleurum root. When one wishes to add powdered red ginseng extract to a formulation for its “action to promote digestive function” and “supplement ‘qi’,” it should probably not be taken at the same time the formulation which include schizonepeta spike. Shakuyaku-kanzo-to consists of licorice and peony. peony has “antispasmodic and analgesic action.” When one wishes to add powdered Shakuyaku-kanzo-to to another formulation for its “antispasmodic and analgesic action.” it should probably not be taken at the same time the formulation which include Polyporus or perilla herb. Kikyo-to consists of licorice and bellflower. Bellflower has “detoxifying and pus-draining action.” When one wishes to add powdered Kikyo-to to another formulation for its “antispasmodic and analgesic action.” it should probably not be taken at the same time the formulation which include dry ginger or aconite.

Conclusion: The current results may provide a basis for considering the appropriateness of mixing different formulation like Kampo extract or adding a crude drug to a formulation.

Keywords

Compatibility; Crude Drug; Herbal medicines; Kampo Extracts; Powdered Aconite

Background and Objective

Typically, an herbal formulation consists of multiple crude drugs of natural origins (denoted here simply as “crude drugs”), and these medicines are efficacious because of the specific combinations of those crude drugs. Formulations consisting of crude drugs were developed over a long period of time based on the compatibility of crude drugs. Even if a person in a certain era devised a new formulation consisting of crude drugs and named it, that herbal medicine’s efficacy was subsequently determined over a long period of time. If it was inefficacious, it disappeared through natural selection. Only those Herbal formulations that many people feel are efficacious have been passed down to the present day. Currently, approximately 150 types of Kampo medicines are used in traditional Japanese medicine in Japan, while about 300 types are stringently selected and used in Chinese medicine in modern China, including those with the same constituents as Kampo medicines. In Japan, 148 types of Kampo formulations are currently covered by health insurance. In addition, approximately 100 types of crude drugs are covered by health insurance. In Japan, many Kampo formulations from several companies are used in daily practice. packaged as an instant extract, these formulations are boiled or provided in the form of a dry powder in advance. As example, aconite [1,2] (an extract with action “to warm and relieve pain”) and red ginseng [3] (an extract with action to “supplement ‘qi’ and relieve fatigue and malaise”) are available as extracts of a single crude drug from Tsumura. 

Typically, a single crude drug has several types of action, so the action of a herbal formulation as a whole often differs from the additive actions of the individual crude drugs that comprise it. When different formulations are taken simultaneously, the crude drugs that comprise them mix in the stomach.

The compatibility of pairs of the crude drug in herbal medicines has not been elucidated. Accordingly, when taking several different types of herbal formulations on the same day, the formulations may need to be taken after a certain interval to prevent them from mixing in the stomach. If incompatible crude drugs mix, the efficacy of each formulation may presumably decrease compared to when each formulation is taken alone. Taking the compatibility of crude drugs into account may allow added crude drugs to have an effect without decreasing overall efficacy. When considering whether to add powdered aconite extract or powdered red ginseng extract or when contemplating taking different Kampo extracts at the same time, the appropriateness of the types of formulations to add is a concern. If pairs of incompatible crude drugs can be identified by the current study, then the effects of adding certain crude drugs or combining formulations may be determined in routine practice.

Materials And Methods

This study examined the compatibility of crude drugs comprising herbal formulations, with a focus on the TOP 40 crude drugs most often contained in Kampo extracts. A total of 324 formulations were studied, including 150 formulations often used in Japan and 174 formulations that are often used in modern China as listed in a textbook from a university of traditional Chinese medicine (Table 1). 

150 Japanese Kampo formulations

 

174 Chinese herbal formulations

Makyo-yokukan-to

Saiboku-to

Hainosankyu-to

 

Seikoryuko-to

Gonin-gan

Tennohoshin-tan

Makyo-kanseki-to

Sairei-to

Bakumondo-to

 

Akyokeishio-to

Eppi-to

Iko-san

Kanbaku-taiso-to

Sannoshashin-to

Hachimijio-gan

 

Keibuunkyu-gan

Etsukiku-gan

Tenmmachoto-in

Anchu-san

Sansonin-to

Hacchin-to

 

Shinka-koju-san

Saikakujio-gan

Tokinentsu-to

Irei-to

Jiinshiho-to

Hangekoboku-to

 

Shinka-oryu-to

Saisen-sen

Tokihoketsu-to

Inchin-gorei-san

Jiinkoka-to

Hangeshashin-to

 

Kanroshodoku-in

Saiko-ka-bosho-to

Tokiryuso-gan

Inchinko-to

Shiun-ko

Hangebyakujutsutemma-to

 

Angyugoou-gan

Saikosokan-san

Tokirokuo-to

Unkei-to

Shigyaku-san

Byakko-ka-ninjin-to

 

Seika-to

Saizo-san

Dokkatsukisei-to

Unsei-in

Shishihakuhi-to

Bukuryo-in

 

Ikkan-sen

Teikan-gan

Shiso-san

Eppika-jutsu-to

Shichimotsukoka-to

Bushirichu-to

 

Shomyaku-san

Teizen-to

Shichihoubihatsu-tan

Ogi-kenchu-to

Saihaku-to

Heii-san

 

Ubai-gan

Sankofukumyaku-to

Seika-to

Orengedoku-to

Saiso-in

Boiogi-to

 

Uzu-to

Sannin-to

Kyogai-to

Oren-to

Shimotsu-to

Bofutsusho-san

 

Ekio-gan

Sanmotsubikyu-gan

Nimyo-san

Otsuji-to

Shakanzo-to

Hochuekki-to

 

Eppi-to

Sanyo-to

Ninjingokai-san

Kakkonka-jutsubu-to

Shakuyakukanzobushi-to

Mao-to

 

Ogikeishigomotsu-to

Jio-inshi

Shokan-to

Kakkon-to

Shakuyakukanzo-to

Maobushisaishin-to

 

Odo-to

Jippi-in

Shoyoekii-to

Kakkonto-ka-senkyushinni

Juzentaiho-to

Mashinin-gan

 

Hohaiakyu-to

Saikatsugeki-to

Haidoku-san

Keima-kakuhan-to

Jumihaidoku-to

Sanmotsuogon-to

 

Hyokango-to

Chibakujio-gan

Baimokarou-san

Keikyo-soso-oshinnbu-to

Juncho-to

Nyoshin-san

 

Untan-to

Saihaku-to

Hakushiyoshin-gan

Keishaku-chimo-to

Shoma-kakkon-to

Yokuinin-to

 

Unpi-san

Shakuyaku-to

Hassho-san

Kamikihi-to

Shokenchu-to

Yokukan-san

 

Unpi-to

Jakoshoki-san

Kagai-san

Kamishoyo-san

Shosaiko-to

Shikunshi-to

 

Kaiyokyukyu-to

Jukai-san

Saki-in

Senkyuchacho-san

Shosaiko-to-ka-kikyosekko

Shirei-to

 

Kosharikkunshi-gan

Shushaanjin-gan

Sakin-gan

Kikyo-to

Shoseiryu-to

Rikkunnshi-to

 

Koren-gan

Shokankyo-to

Byakugokokin-to

Ogon-to

Shohange-ka-bukuryo-to

Ryutanshakan-to

 

Kakukachikuo-to

Shokyoshashin-to

Fukugenkakketsu-to

Kihi-to

Shofu-san

Ryokankyomishingenin-to

 

Kagenfukumyaku-to

Shokei-inshi

Fukuhodaijoki-to

Mokuboi-to

Shinniseihai-to

Ryokeijutsukan-to

 

Kosho-to

Jotan-to

Bukuryo-gan

Kumibinro-to

Jinso-in

Ryokyojutsukan-to

 

Kakkonnogonoren-to

Seifu-to

Fuseishodoku-in

Kyukikyogai-to

Shinpi-to

Renju-in

 

Keiryokannro-in

Shofukuchikuo-to

Bushi-to

Kyukichoketsu-in

Shinbu-to

Rokumi-gan

 

Kamiuyaku-san

Hakutoo-to

Boibukuryo-to

seishoeki-to

Seijobofu-to

 

 

Shinsui-tan

Jingyoryuko-san

Bofu-to

Seishinrenshi-in

Seihai-to

 

 

Kantai-to

Shinka-koju-san

Hogen-to

Keigairengyo-to

Sessho-in

 

 

Kanzokankyobukuryobyakujutsu-to

Ryokaku-san

Borei-san

Keishi-ka-ogi-to

Sokeikakketsu-to

 

 

Kanzoshashin-to

Senfukudaiseki-to

Jinbu-to

Keishi-ka-kakkonn-to

Daiokanzo-to

 

 

Ogon-to

Senpokatsumei-in

Jinryobyakujutsu-san

Keishi-ka-kobokukyonin-to

Daiobotanpi-to

 

 

Kijitsushohi-gan

Zoekijoki-to

Ekii-to

Keishi-ka-shakuyakudaio-to

Daikenchu-to

 

 

Kijitsudotai-gan

Sogoko-gan

Shinjinyozo-to

Keishi-ka-shakuyaku-to

Daisaiko-to

 

 

Kumikyokatsu-to

Soshikoki-to

Doseki-san

Keishi-ka-jutsubu-to

Daisaiko-to-kyo-daio

 

 

Kyusen-san

Shasei-gan

Dotan-to

Keishi-ka-ryukotsuborei-to

Daijoki-to

 

 

Seii-san

Daiseiryu-to

Shintsuchikuo-to

Keishi-ka-ryojutsubu-to

Daibofu-to

 

 

Kyokatsushoshitsu-to

Daiobushi-to

Shisetsu-tan

Keishinieppi-itto

Chikujountan-to

 

 

Kyoso-san

Daihoin-gan

Mokkobinro-gan

Keishininjin-to

Rikko-san

 

 

Seiei-to

Daikankyo-to

Shisei-gan

Keishibukuryo-gan

Jiziso-ippo

 

 

Seitai-to

Daiteifuju-to

Tokoshimotsu-to

Keishibukuryogan-ka-yokuinin

Jidaboku-ippo

 

 

Seiunhaidoku-san

Daijingyo-to

Yoinseihai-to

Keishi-to

Choijoki-to

 

 

Seikiketan-to

Chikuyosekko-to

Taizanbanjaku-san

Keihi-to

Choto-san

 

 

Seisokyuhai-to

Chikuyoryubo-to

Yowa-to

Koso-san

Choyo-to

 

 

Seikotsu-in

Kikkaku-gan

Shishin-gan

Goko-to

Chorei-to

 

 

Gingyo-san

Kippichikujo-to

Shigyaku-to

Goshaku-san

Tokakujoki-to

 

 

Sokyo-to

Gyokueki-to

Richu-gan

Goshajinki-gan

Tokikenchu-to

 

 

Sokiku-in

Gyokujo-sen

Ryokangomikyoshin-to

Goshuyu-to

Tokishakuyaku-san

 

 

Sohyosho-san

Gyokubyobu-san

Reikakuchoto-to

Shojoki-to

Toki-inshi

 

 

Keibohaidoku-san

Gyokushin-san

Renju-in

Gorin-san

Toki-to

 

 

keppuchikuo-to

Howa-gan

Rokuwa-to

Gorei-san

Tokishigyaku-ka-goshuyushokyo-to

 

 

Kenhi-gan

Dankan-sen

 

Saikan-to

Tsudo-san

 

 

Kogonseitan-to

Tsukyokakketsu-to

 

Saikoseikan-to

Nijutsu-to

 

 

Kobokuunchu-to

Tsusha-yoho

 

Saiko-ka-ryukotsuborei-to

Nichin-to

 

 

Oryu-to

Boi-gan

 

Saikokeishikankyo-to

Ninjin-to

 

 

Gohi-san

Zokumei-to

 

Saikokeishi-to

Ninjinyoei-to

 

 

Kokei-gan

Chokoshitei-to

 

Table 1: The formulations studied (150 Kampo formulations + 174 Chinese herbal formulations).

To identify pairs of crude drugs that do not coexist in any of the formulations studied, the following procedures (1) and (2) were performed in sequence. Procedure (1): Crude drugs comprising all of the formulations studied were entered in Excel. Formulations were sorted in descending order by the crude drugs they consisted of. Formulations containing crude drug A were selected, and those not containing crude drug B were identified. Procedure (2): Formulations containing crude drug B were selected, and they were checked to see whether or not they contained crude drug A. 

Through procedures (1) and (2), pairs of crude drugs (AB) were identified, i.e., “crude drug B is not present in formulations containing crude drug A, and crude drug A is not present in formulations containing crude drug B.” When the conditions above were satisfied, pairs of crude drugs (AB) that did not coexist were identified and designated “non-coexisting pairs” of crude drugs. Non-coexisting pairs of crude drugs are likely to be incompatible. 

This study was approved by the ethics review board of this facility.

Results

Non-coexisting pairs are shown in table 2. Based on the current results, there were no crude drugs that were incompatible with licorice [4] or ginger. bellflower [5], pinellia tuber, and bupleurum root [6,7] were identified as crude drugs that may be incompatible with aconite. Schizonepeta spike was identified as a crude drug that is potentially incompatible with ginseng. Polyporus and perilla herb were identified as crude drugs that are potentially incompatible with peony [8]. The following pairs of crude drugs may be incompatible. Peach kernel [9] and coptis chinensis [10,11], rhubarb [12,13] and astragalus membranaceus [14], angelica acutiloba [15] and japanese yam, ephedra herb [16] and coptis chinensis, anemarrhena [17] and dried ginger [18], magnolia officinalis [19] and plaster, poria [20] and sodium sulfate, and pinellia tuber and rehmannia root [21]. In regard to non-coexisting pairs AB which are shown in table 2, number of formulations included crude drug A or B is respectively shown in table 3. The higher number of formulations included A×number of formulations included B is, the higher a possibility of existence of non-coexisting pair AB. Accordingly, most incompatible pair is thought to be pinellia tuber - rehmannia root. 

Non-coexisting pears

Dried ginger

×

Gardenia fruit

×

Moutan bark

×

Anemarrhena

×

Fruit

×

Ophiopogon japonicus

×

Bellflower

Jujube

×

Japanese yam

×

Schizonepeta spike

×

Peach kernel

×

Phellodendron bark

×

Anemarrhena

Magnolia  officinalis

×

Moutan bark

×

Plaster

×

Anemarrhena

×

Ophiopogon japonicus

×

Windbreak fence

Astragalus membranaceus

×

Moutan bark

×

Plaster

×

Almond kernel

×

Fruit

Coptis chinensis

×

Peach kernel

×

Plaster

×

Almond kernel

×

Atractylodes rhizome

Aconite

×

Pinellia tuber

×

Bellflower

×

Bupleurum root

Sodium sulfate

×

Poria

×

Citrus unshiu peel

×

Atractylodes rhizome

Ephedra

×

Moutan bark

×

Coptis chinensis

×

Ophiopogon japonicus

Pinellia tuber

×

Rehmannia root

×

Japanese yam

×

Peach kernel

Rhubarb

×

Astragalus membranaceus

×

Anemarrhena

Cnidium rhizome

×

Japanese yam

×

Almond kernel

Peony

×

Polyporus

×

Perilla herb

Ginseng

×

Schizonepeta spike

Huang jin

×

Japanese yam

Baizhu

×

Almond kernel

Atractylodes rhizome

×

Almond kernel

Alismatis rhizome

×

Ophiopogon japonicus

Angelica acutiloba

×

Japanese yam

Table 2: The non-coexisting pairs in the formulations studied. 

Crude drug A

Number of Formulations

 

Crude drug B

Number of Formulations

 

(1)×(2)

including Crude drug A (1)

including Crude drug B (2)

Pinellia tuber

54

×

Rehmannia root

60

 

3240

Atractylodes rhizome

42

×

Coptis chinensis

37

 

1554

Cnidium rhizome

53

×

Almond kernel

27

 

1431

Jujube

66

×

Anemarrhena

21

 

1386

Sodium sulfate

15

×

Poria

91

 

1365

Pinellia tuber

54

×

Aconite

25

 

1350

Jujube

66

×

Phellodendron bark

19

 

1254

Jujube

66

×

Peach kernel

18

 

1188

Coptis chinensis

37

×

Ephedra

31

 

1147

Atractylodes rhizome

42

×

Almond kernel

27

 

1134

Japanese yam

14

×

Angelica acutiloba

81

 

1134

Baizhu

41

×

Almond kernel

27

 

1107

Astragalus membranaceus

30

×

Rhubarb

36

 

1080

Coptis chinensis

37

×

Almond kernel

27

 

999

Pinellia tuber

54

×

Peach kernel

18

 

972

Ophiopogon japonicus

30

×

Ephedra

31

 

930

Peony

93

×

Polyporus

10

 

930

Peony

93

×

Perilla herb

10

 

930

Bupleurum root

37

×

Aconite

25

 

925

Japanese yam

14

×

Jujube

66

 

924

Schizonepeta spike

11

×

Ginseng

84

 

924

Dried ginger

30

×

Bellflower

30

 

900

Ophiopogon japonicus

30

×

Magnolia  officinalis

30

 

900

Ophiopogon japonicus

30

×

Dried ginger

30

 

900

Coptis chinensis

37

×

Plaster

24

 

888

Windbreak fence

28

×

Magnolia  officinalis

30

 

840

Japanese yam

14

×

Huang jin

58

 

812

Astragalus membranaceus

30

×

Almond kernel

27

 

810

Gardenia fruit

27

×

Dried ginger

30

 

810

Japanese yam

14

×

Pinellia tuber

54

 

756

Rhubarb

36

×

Anemarrhena

21

 

756

Bellflower

30

×

Aconite

25

 

750

Fruit

25

×

Astragalus membranaceus

30

 

750

Fruit

25

×

Dried ginger

30

 

750

Ephedra

31

×

Moutan bark

24

 

744

Japanese yam

14

×

Cnidium rhizome

53

 

742

Sodium sulfate

15

×

Citrus unshiu peel

49

 

735

Jujube

66

×

Schizonepeta spike

11

 

726

Magnolia  officinalis

30

×

Moutan bark

24

 

720

Magnolia  officinalis

30

×

Plaster

24

 

720

Dried ginger

30

×

Moutan bark

24

 

720

Astragalus membranaceus

30

×

Moutan bark

24

 

720

Astragalus membranaceus

30

×

Plaster

24

 

720

Coptis chinensis

37

×

Peach kernel

18

 

666

Ophiopogon japonicus

30

×

Alismatis rhizome

22

 

660

Atractylodes rhizome

42

×

Sodium sulfate

15

 

630

Magnolia  officinalis

30

×

Anemarrhena

21

 

630

Dried ginger

30

×

Anemarrhena

21

 

630

Table 3: Number of formulations included crude drug A or B in regard to non-coexisting pairs AB which are shown in table 2. 

Discussion

Pairs of crude drugs that are incompatible are presumed to have been eliminated from formulations through natural selection over a long period of time. As a result, the combinations of crude drugs in the 324 formulations studied have stood the test of time.

The non-coexisting pairs shown in table 2 were systematically organized, yielding the following findings. When one wishes to mix one formulation with the other or when one wishes to add a crude drug to a formulation, “right or wrong” should be taken into consideration based on the current results to avoid mixing of incompatible crude drug in the stomach. 

The crude drugs comprising Kampo formulations tended to contain jujube [22], ginger, and licorice in comparison to traditional Chinese medicine formulations. Licorice has action to “harmonize various drugs,” ginger has action to “promote digestion”. there were no crude drugs that were incompatible with licorice or ginger. In case of taking the formulation that include jujube, it should probably not be taken at the same time the formulation which include the crude drugs like gardenia fruit, moutan bark, anemarrhena, Ophiopogon japonicus, and bellflower. 

White atractylodes (Baizhu) is often used in traditional Chinese medicine formulations (white atractylodes: atractylodes rhizome = 27: 5), while atractylodes rhizome is often used in Kampo formulations (white atractylodes: atractylodes rhizome = 14: 35). Both atractylodes and white atractylodes are often found to be incompatible with almond kernel [23]. In case of taking the formulation that include atractylodes or white atractylodes, it should probably not be taken at the same time the formulation which include almond kernel. 

When one wishes to add powdered aconite extract to a formulation for its “warming and analgesic action,” it should probably not be taken at the same time the formulation which include bellflower, pinellia tuber, or bupleurum root. When one wishes to add powdered red ginseng extract to a formulation for its “action to promote digestive function” and “supplement ‘qi’,” it should probably not be taken at the same time the formulation which include schizonepeta spike. 

Shakuyaku-kanzo-to consists of licorice and peony. peony has “antispasmodic and analgesic action.” When one wishes to add powdered Shakuyaku-kanzo-to to another formulation for its “antispasmodic and analgesic action.” it should probably not be taken at the same time the formulation which include Polyporus or perilla herb. Kikyo-to consists of licorice and bellflower. Bellflower has “detoxifying and pus-draining action.” When one wishes to add powdered Kikyo-to to another formulation for its “antispasmodic and analgesic action.” it should probably not be taken at the same time the formulation which include dry ginger or aconite. 

Considering above, when several different formulations are taken, it may be safe to leave a time interval required for digestion to take medicine.

Conclusion

The current results may provide a basis for considering the appropriateness of mixing different formulations like Kampo extract or adding a crude drug to a formulation.

References

  1. Sato H, Yamada C, Konno C, Ohizumi Y, Endo K, et al. (1979). Pharmacological Actions of Aconitine Alkaloids. Tohoku J exp Med 128: 175-187.
  2. Gao X, Hu J, Zhang X, Zuo Y, Wang Y, et al (2020) Research progress of aconitine toxicity and forensic analysis of aconitine poisoning. Forensic Sciences Research 5: 25-31.
  3. Kaneko H, Nakanishi K (2004) Proof of the Mysterious Efficacy of Ginseng: Basic and Clinical Trials: Clinical Effects of Medical Ginseng, Korian Red Ginseng: Specifically, Its Anti-stress Action for Prevention of Disease. J Pharmacol Sci 95: 158-162.
  4. Yang R, Yuan BC, Ma YS, Zhou S, Liu Y (2017) The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharma Biol 55: 5-18.
  5. Gil NY, Gwon HM, Yeo SH, Kim SY (2020) Metabolite Profile and Immunomodulatory Properties of Bellflower Root Vinegar Produced Using Acetobacter pasteurianus A11-2. Foods 9: 1063.
  6. Ran S, Peng R, Guo Q, Cui J, Chen G, et al. (2024) Bupleurum in Treatment of Depression Disorder: A Comprehensive Review. Pharmaceuticals 12: 512.
  7. Ashour ML, Wink M (2011) Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action. J Pharmacy and Pharmacology 63: 305-321.
  8. Kamenetsky-Goldstein R, Yu X (2022) Cut peony industry: the first 30 years of research and new horizons. Horticulture Reseach 9: 79.
  9. Shirahata T, Kanazawa A, Uematsu M, Fuchino H, Kawano N, et al. (2022) Near-Infrared Metabolic Profiling for Discrimination of Apricot and Peach Kernels. Chem Pharm Bull 70: 863-867.
  10. Li M, Tian F, Guo J, Li X, Ma L, et al. (2023) Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms. Frontiers in Pharmacology Open Access 14: 1243820.
  11. Tseng CY, Sun MF, Li TC, Lin CT (2020) Effect of Coptis chinensis on Biofilm Formation and Antibiotic Susceptibility in Mycobacterium abscessus. Evid Based Complementary Altern Med 9754357: 9
  12. Jin K, Tian Y, Xin J, Inoue M, Setsu K, et al. (2005) Hepatotoxicity Induced by Excessive Intake of Rhubarb. J Hard Tisssue Biology 15: 16-19.
  13. Lai F, Zhang Y, Xie DP, Mai ST, Weng YN, et al. (2015) A Systematic Review of Rhubarb (a Traditional Chinese Medicine) Used for the Treatment of Experimental Sepsis. Evid Based Complementary Altern Med 131283: 12.
  14. Liu P, Zhao H, Luo Y (2017) Anti-Aging Implications of Astragalus Membranaceus (Huangqi) : A Well-Known Chinese Tonic. Aging Disease 8: 868-886.
  15. Yun JW, Kwon E, Kim SH, You JR, Kim YS, et al. (2017) Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats. Lab Anim Res 33: 223-230.
  16. Hikino H, Konno C, Takata H, Tamada M (1980) Antiinflammatory Principle of Ephedra Herbs. Chem Pharma Bull 28: 2900-2904.
  17. Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, et al. (2001) Antidiabetic Activity of the Rhizoma of Anemarrhena asphodeloides and Active Components, Mangiferin and Its Glucoside. Biol Pharm Bull 24: 1009-1011.
  18. Mustafa I, Chin NL (2023) Antioxidant Properties of Dried Ginger (Zingiber officinale Roscoe) var. Bentong. Food 12: 178.
  19. Poivre M, Duez P (2017) Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E.Wilson (Houpo) and its constituents. Poivre and Duez J Zhenjiang Univ-Sci 18: 194-214.
  20. Cuellar MJ, Giner RM, Recio MC, Just MJ, Mañez S, et al. (1996) Effect of the Basidiomycete Poria cocos on Experimental Dermatitis and Other Inflammatory Conditions. Chem Pharm Bull 45: 492-494.
  21. Huang Y, Ando H, Tsujino M, Yoshihara K, Zhang L, et al. (2022). Study on Catalpol Content in Rehmannia glutinosa Root, an Important Ingredient in Kampo Prescriptions. Biol Pharma Bull 45: 955-961.
  22. Zhu D, Jiang N, Wang N, Zhao Y, Liu X (2024) A Literature Review of the Pharmacological Effects of Jujube. Foods 13:193.
  23. Matthäus B, Özcan MM, Juhaimi FA, Adiamo OQ, Alsawmahi ON, et al. (2018) Effect of the Harvest Time on Oil Yield, Fatty Acid, Tocopherol and Sterol Contents of Developing Almond and Walnut Kernels. J Oleo Sci 67: 39-45.

Citation: Isobe T, Kaijima M, Kaijima M, Kaijima H (2025) A study on the Compatibility of Crude Drugs Comprising Kampo Medicines. HSOA J Altern Complement Integr Med 11: 647.

Copyright: © 2025  Tetsuya Isobe, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Herald Scholarly Open Access is a leading, internationally publishing house in the fields of Science. Our mission is to provide an access to knowledge globally.



© 2025, Copyrights Herald Scholarly Open Access. All Rights Reserved!